Skip to Main Content

INFORMATION FOR

    Diseases of the Cardiovascular System, Phase III

    Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

    What is the purpose of this trial?

    The CORCINCH-HF Study is evaluating the safety and efficacy of the AccuCinch® Ventricular Restoration System, a new and innovative device-based approach to treating heart failure that is designed to improve the structure and function of the heart and may help reduce symptoms, improve quality of life and potentially increase life expectancy.

    During the minimally invasive AccuCinch procedure, a flexible implant is attached to the interior of the mid left ventricular wall and then cinched. The implant is intended to reduce the size of the left ventricle, reduce ventricular wall stress, and support and strengthen the heart wall.

    • Trial with
      Ancora Heart, Inc.
    • Ages
      18 years and older
    • Gender
      Both

    Contact Information

    For more information about this study, including how to volunteer, contact Arben Ademi, MD, CCRP

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    • Last Updated
      06/09/2024
    • Study HIC
      #2000028335